2025 ICD-10-CM Diagnosis Code E06.4

Drug-induced thyroiditis

E06.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2025 edition of ICD-10-CM E06.4 became effective on October 1, 2024.
This is the American ICD-10-CM version of E06.4 – other international versions of ICD-10 E06.4 may differ.

Use Additional

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

The following code(s) above E06.4 contain annotation back-references

that may be applicable to E06.4:

Approximate Synonyms

ICD-10-CM E06.4 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):

011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
643 Endocrine disorders with mcc
644 Endocrine disorders with cc
645 Endocrine disorders without cc/mcc

Convert E06.4 to ICD-9-CMCode History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change
2023 (effective 10/1/2022): No change
2024 (effective 10/1/2023): No change
2025 (effective 10/1/2024): No change

Diagnosis Index entries containing back-references to E06.4: